| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $182.9M | +21.0% |
| Cost of Revenue | $79.4M | +27.0% |
| Gross Profit | $103.5M | +16.8% |
| R&D Expense | $7.1M | +16.8% |
| SG&A Expense | $199.6M | +132.6% |
| Operating Income | -$96.2M | -3605.1% |
| Interest Expense | $4.6M | +30.0% |
| Pre-tax Income | -$97.2M | -8141.9% |
| Income Tax | -$5.2M | -298.8% |
| Net Income | -$92.0M | -6114.0% |
| EPS (Basic) | -$7.76 | — |
| EPS (Diluted) | -$7.76 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $8.0M | +31.2% |
| Inventory | $5.5M | +40.3% |
| Current Assets | $35.4M | -21.4% |
| Total Assets | $118.1M | -44.8% |
| Current Liabilities | $59.6M | -6.3% |
| Long-term Debt | $6.6M | -54.1% |
| Total Liabilities | $69.7M | -33.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.4M | +6.0% |
| Capital Expenditures | $6.2M | -13.7% |
| Investing Cash Flow | -$22.0M | +41.2% |
| Financing Cash Flow | -$19.4M | -170.0% |
| Free Cash Flow | $19.2M | +14.5% |
| $46.5M |
| -55.7% |